Interventional Cardiology & Peripheral Vascular Devices Market Report
RA01178
Interventional Cardiology & Peripheral Vascular Devices Market, by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global interventional cardiology & peripheral vascular devices market is estimated to surpass $40,087.9 million by 2027, exhibiting a CAGR of 9.6% from 2020 to 2027.
The report provides all-inclusive analysis of global interventional cardiology & peripheral vascular devices market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
The report emphasizes current market scenario and future trends of the global interventional cardiology & peripheral vascular devices market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global interventional cardiology & peripheral vascular devices market.
In addition, the report provides market size and forecast scrutinizing global interventional cardiology & peripheral vascular devices market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global interventional cardiology & peripheral vascular devices market. In the report, the global interventional cardiology & peripheral vascular devices market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover interventional cardiology & peripheral vascular devices market landscape in respective regions.
Furthermore, competitive scenario of the global interventional cardiology & peripheral vascular devices market is covered in the report. Major players functioning in the global interventional cardiology & peripheral vascular devices market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global interventional cardiology & peripheral vascular devices market, and others.
RESEARCH METHODOLOGY
The research report is drafted by in-house research analysts who sincerely examine the market scenario and form predictions. The market forecasts specified in the report have been derived using proven research approaches and analytical models & tools. The use of such pioneering and effective tools helps market analysts in analyzing, filtering, and providing highly precise statistics and estimates. The report provides an extensive research and analysis backed with factual data obtained from various interviews with market players, reliable and renowned sources of data, and regional intelligence. The insights provided in the report can help investors, stakeholders, and market players to understand investment suitability and seize opportunities for advancements, investments, and partnerships in the global interventional cardiology & peripheral vascular devices market.
The research report is formulated by collecting different information, news, and statistics about the interventional cardiology & peripheral vascular devices market. For instance, detailed interviews and discussions with veteran market players and stakeholders, including upstream and downstream members have been conducted to obtain reliable and realistic data. Even though primary research forms the crucial part of the research report, secondary research plays a significant role in backing the research outcomes. Nearly 5,900 product type literatures, business magazines, company annual reports, and other such significant documents of leading market players have been considered and studied for thorough understanding of the market scenario. In addition, truthful industry bulletins, medical newsletters, trade associations’ journals, and government websites have been explored for tracking down high-value market insights.
KEY MARKET BENEFITS
- The report provides the market size and predictions for the period from 2019 to 2027
- This report delivers inventions, trends, and innovative developments along with an exhaustive quantitative analysis of the interventional cardiology & peripheral vascular devices market during the period of forecast
- The prevailing and forthcoming investment opportunities along with the strategic assessment of the global interventional cardiology & peripheral vascular devices market growth is delivered
- The market size and forecasts are derived by scrutinizing market boomers and restraints, and key developments in the interventional cardiology & peripheral vascular devices market
- Insights into foremost market players, Porter’s Five Analysis, and top winning business strategies is provided
- Growth tactics and initiatives taken by the top market players are outlined to understand the competitive scenario and strength of the market
KEY MARKET SEGMENTS
The report segments the global market into product and region.
- Product: Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Accessories
Regionally, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The global interventional cardiology & peripheral vascular devices market is consolidated with the presence of large number of key players. These players are increasingly focusing on innovation, geographical expansion of product portfolios, and novel developments to obtain a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.
Players in global interventional cardiology & peripheral vascular devices market include:
1. Abbott Laboratories
2. B. Braun Melsungen AG
3. Boston Scientific Corporation
4. C. R. Bard, Inc.
5. Cardinal Health, Inc.
6. Cook Medical, Inc.
7. Medtronic plc
8. St. Jude Medical, Inc.
9. Terumo Corporation
10. The Spectranetics Corporation
11. Edwards Lifesciences Corporation
12. ABIOMED, Inc.
13. AngioDynamics, Inc.
14. Becton
15. Dickinson & Co.
16. Lepu Medical Technology (Beijing) Co. Ltd.
17. Baxter International Inc.
18. Siemens AG
19. 3M Company
20. Biotronik SE & Co. KG
21. Smith & Nephew plc
22. Sahajananad Medical Technologies Ltd.
23. HeartWare International, Inc.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Interventional Cardiology & Peripheral Vascular Devices Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Interventional Cardiology & Peripheral Vascular Devices Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Interventional Cardiology & Peripheral Vascular Devices Market, By Sector
5.1. Overview
5.2 Angioplasty Balloons
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Angioplasty Stents
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Angioplasty Catheters
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Endovascular Aneurysm Repair Stent Grafts
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Inferior Vena Cava (IVC) Filters
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Plaque Modification Devices
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Hemodynamic Flow Alteration Devices
5.8.1 Definition, key trends, growth factors, and opportunities
5.8.2 Market size analysis, by region, 2020-2027
5.8.3 Market share analysis, by country, 2020-2027
5.9 Accessories
5.9.1 Definition, key trends, growth factors, and opportunities
5.9.2 Market size analysis, by region, 2020-2027
5.9.3 Market share analysis, by country, 2020-2027
5.10 Research Dive Exclusive Insights
5.10.1 Market attractiveness
5.10.2 Competition heatmap
6. Interventional Cardiology & Peripheral Vascular Devices Market, By Region
6.1 North America
6.1.1 U.S
6.1.1.1 Market size analysis, By Sector, 2020-2027
6.1.2 Canada
6.1.2.1 Market size analysis, By Sector, 2020-2027
6.1.3 Mexico
6.1.3.1 Market size analysis, By Sector, 2020-2027
6.1.4 Research Dive Exclusive Insights
6.1.4.1 Market attractiveness
6.1.4.2 Competition heatmap
6.2 Europe
6.2.1 Germany
6.2.1.1 Market size analysis, By Sector, 2020-2027
6.2.2 UK
6.2.2.1 Market size analysis, By Sector, 2020-2027
6.2.3 France
6.2.3.1 Market size analysis, By Sector, 2020-2027
6.2.4 Spain
6.2.4.1 Market size analysis, By Sector, 2020-2027
6.2.5 Italy
6.2.5.1 Market size analysis, By Sector, 2020-2027
6.2.6 Rest of Europe
6.2.6.1 Market size analysis, By Sector, 2020-2027
6.2.7 Research Dive Exclusive Insights
6.2.7.1 Market attractiveness
6.2.7.2 Competition heatmap
6.3 Asia-Pacific
6.3.1 China
6.3.1.1 Market size analysis, By Sector, 2020-2027
6.3.2 Japan
6.3.2.1 Market size analysis, By Sector, 2020-2027
6.3.3 India
6.3.3.1 Market size analysis, By Sector, 2020-2027
6.3.4 Australia
6.3.4.1 Market size analysis, By Sector, 2020-2027
6.3.5 South Korea
6.3.5.1 Market size analysis, By Sector, 2020-2027
6.3.6 Rest of Asia-Pacific
6.3.6.1 Market size analysis, By Sector, 2020-2027
6.3.7 Research Dive Exclusive Insights
6.3.7.1 Market attractiveness
6.3.7.2 Competition heatmap
6.4 LAMEA
6.4.1 Brazil
6.4.1.1 Market size analysis, By Sector, 2020-2027
6.4.2 Saudi Arabia
6.4.2.1 Market size analysis, By Sector, 2020-2027
6.4.3 UAE
6.4.3.1 Market size analysis, By Sector, 2020-2027
6.4.4 South Africa
6.4.4.1 Market size analysis, By Sector, 2020-2027
6.4.5 Rest of LAMEA
6.4.5.1 Market size analysis, By Sector, 2020-2027
6.4.6 Research Dive Exclusive Insights
6.4.6.1 Market attractiveness
6.4.6.2 Competition heatmap
7. Competitive Landscape
7.1 Top winning strategies, 2020-2027
7.1.1 By strategy
7.1.2 By year
7.2 Strategic overview
7.3 Market share analysis, 2020-2027
8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Business segments
8.1.3 Product portfolio
8.1.4 Financial performance
8.1.5 Recent developments
8.1.6 SWOT analysis
8.2 B. Braun Melsungen AG
8.2.1 Overview
8.2.2 Business segments
8.2.3 Product portfolio
8.2.4 Financial performance
8.2.5 Recent developments
8.2.6 SWOT analysis
8.3 Boston Scientific Corporation
8.3.1 Overview
8.3.2 Business segments
8.3.3 Product portfolio
8.3.4 Financial performance
8.3.5 Recent developments
8.3.6 SWOT analysis
8.4 C. R. Bard, Inc.
8.4.1 Overview
8.4.2 Business segments
8.4.3 Product portfolio
8.4.4 Financial performance
8.4.5 Recent developments
8.4.6 SWOT analysis
8.5 Cardinal Health, Inc.
8.5.1 Overview
8.5.2 Business segments
8.5.3 Product portfolio
8.5.4 Financial performance
8.5.5 Recent developments
8.5.6 SWOT analysis
8.6 Cook Medical, Inc.
8.6.1 Overview
8.6.2 Business segments
8.6.3 Product portfolio
8.6.4 Financial performance
8.6.5 Recent developments
8.6.6 SWOT analysis
8.7 Medtronic plc
8.7.1 Overview
8.7.2 Business segments
8.7.3 Product portfolio
8.7.4 Financial performance
8.7.5 Recent developments
8.7.6 SWOT analysis
8.8 St. Jude Medical, Inc.
8.8.1 Overview
8.8.2 Business segments
8.8.3 Product portfolio
8.8.4 Financial performance
8.8.5 Recent developments
8.8.6 SWOT analysis
8.9 Terumo Corporation
8.9.1 Overview
8.9.2 Business segments
8.9.3 Product portfolio
8.9.4 Financial performance
8.9.5 Recent developments
8.9.6 SWOT analysis
8.10 The Spectranetics Corporation
8.10.1 Overview
8.10.2 Business segments
8.10.3 Product portfolio
8.10.4 Financial performance
8.10.5 Recent developments
8.10.6 SWOT analysis
8.11 Edwards Lifesciences Corporation
8.11.1 Overview
8.11.2 Business segments
8.11.3 Product portfolio
8.11.4 Financial performance
8.11.5 Recent developments
8.11.6 SWOT analysis
8.12 ABIOMED, Inc.
8.12.1 Overview
8.12.2 Business segments
8.12.3 Product portfolio
8.12.4 Financial performance
8.12.5 Recent developments
8.12.6 SWOT analysis
8.13 AngioDynamics, Inc.
8.13.1 Overview
8.13.2 Business segments
8.13.3 Product portfolio
8.13.4 Financial performance
8.13.5 Recent developments
8.13.6 SWOT analysis
8.14 Becton
8.14.1 Overview
8.14.2 Business segments
8.14.3 Product portfolio
8.14.4 Financial performance
8.14.5 Recent developments
8.14.6 SWOT analysis
8.15 Dickinson & Co.
8.15.1 Overview
8.15.2 Business segments
8.15.3 Product portfolio
8.15.4 Financial performance
8.15.5 Recent developments
8.15.6 SWOT analysis
8.16 Lepu Medical Technology (Beijing) Co. Ltd.
8.16.1 Overview
8.16.2 Business segments
8.16.3 Product portfolio
8.16.4 Financial performance
8.16.5 Recent developments
8.16.6 SWOT analysis
8.17 Baxter International Inc.
8.17.1 Overview
8.17.2 Business segments
8.17.3 Product portfolio
8.17.4 Financial performance
8.17.5 Recent developments
8.17.6 SWOT analysis
8.18 Siemens AG
8.18.1 Overview
8.18.2 Business segments
8.18.3 Product portfolio
8.18.4 Financial performance
8.18.5 Recent developments
8.18.6 SWOT analysis
8.19 3M Company
8.19.1 Overview
8.19.2 Business segments
8.19.3 Product portfolio
8.19.4 Financial performance
8.19.5 Recent developments
8.19.6 SWOT analysis
8.20 Biotronik SE & Co. KG
8.20.1 Overview
8.20.2 Business segments
8.20.3 Product portfolio
8.20.4 Financial performance
8.20.5 Recent developments
8.20.6 SWOT analysis
8.21 Smith & Nephew plc
8.21.1 Overview
8.21.2 Business segments
8.21.3 Product portfolio
8.21.4 Financial performance
8.21.5 Recent developments
8.21.6 SWOT analysis
8.22 Sahajananad Medical Technologies Ltd.
8.22.1 Overview
8.22.2 Business segments
8.22.3 Product portfolio
8.22.4 Financial performance
8.22.5 Recent developments
8.22.6 SWOT analysis
8.23 HeartWare International, Inc.
8.23.1 Overview
8.23.2 Business segments
8.23.3 Product portfolio
8.23.4 Financial performance
8.23.5 Recent developments
8.23.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
